Garne, E <br/><br/>
Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy - a cohort linkage study.  [electronic resource] 

 -  BJOG : an international journal of obstetrics and gynaecology  Sep 2016 
 - 1609-18 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1471-0528 
<br/><br/><label>Standard No.: </label>10.1111/1471-0528.14026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abnormalities, Drug-Induced--epidemiology<br/>Acute Kidney Injury--epidemiology<br/>Adrenal Cortex Hormones--administration & dosage<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Adult<br/>Aerosols--adverse effects<br/>Anti-Asthmatic Agents--administration & dosage<br/>Anus, Imperforate--epidemiology<br/>Asthma--drug therapy<br/>Cohort Studies<br/>Denmark--epidemiology<br/>Female<br/>Heart Defects, Congenital--epidemiology<br/>Humans<br/>Infant, Newborn<br/>Norway--epidemiology<br/>Pregnancy<br/>Pregnancy Complications--epidemiology<br/>Pregnancy Trimester, First<br/>Prenatal Exposure Delayed Effects--epidemiology<br/>Prevalence<br/>Registries<br/>Research Design--statistics & numerical data<br/>Risk Factors<br/>Wales--epidemiology